Sidra Medicine, Children’s Hospital Los Angeles sign agreement for expansion of paediatric heart care

featured-image

Tribune News NetworkDohaSidra Medicine, a member of Qatar Foundation, has signed a memorandum of understanding (MoU) with Children’s Hospital Los Angeles (CHLA), marking the beginn...

Qatar tribune Tribune News Network Doha Sidra Medicine, a member of Qatar Foundation, has signed a memorandum of understanding (MoU) with Children’s Hospital Los Angeles (CHLA), marking the beginning of a new collaboration between the two leading paediatric healthcare institutions. The partnership will develop a comprehensive and collaborative patient care, education, and clinical research programme between Sidra Medicine’s Heart Center and CHLA, aimed at enhancing knowledge exchange and access to complex paediatric cardiac care across the MENA region. Dr Iyabo Tinubu-Karch, chief executive officer of Sidra Medicine, said: “Sidra Medicine is proud to be part of an international collaboration with Children’s Hospital Los Angeles, which represents a bold step toward redefining how institutions work together across borders.

By combining our strengths and expertise, we are strengthening a culture of innovation, knowledge exchange, and a shared vision for the future of paediatric care.” Lara Khouri, president and chief operating officer of CHLA, said: “Each year, CHLA provides care and treatments for children from all 50 US states and more than 90 countries worldwide. Our mission is to create hope and build healthier futures for children everywhere, and this collaboration will enable CHLA to extend its scientific and clinical expertise to Sidra Medicine, covering areas of mutual interest and growth.



We look forward to working jointly with the Sidra Medicine teams to advance medical services, leading-edge research, and exceptional patient care.” As part of the patient care programme, both institutions will coordinate transfer and treatment of paediatric patients with highly complex cardiac conditions. Children in Qatar who require advanced surgical interventions not available locally will be referred to CHLA, while patients from the MENA region who receive surgery at CHLA will have the option to continue their treatment at Sidra Medicine.

The collaboration will also explore opportunities for future partnerships across other specialties and sub-specialties. Dr Hesham Al Saloos, Division Chief of Cardiology, Heart Center at Sidra Medicine, said: “This collaboration brings together two leading centres with world-class cardiac services that share a commitment to advancing paediatric cardiology. “Our partnership with CHLA will open new avenues of care and cure, for some of the rarest and most challenging heart conditions in children.

By streamlining our clinicalcare pathways and exchanging expertise, we will ensure that more patients can benefit from world-class cardiac treatment closer to home.” g paediatric healthcare. Yadira Torres, executive director of CHLA’s Center for Global Health, said: “The partnership is built on camaraderie and shared goals to enhance best practices.

CHLA is consistently ranked as a top 10 US children’s hospital in the US News & World Report Best Children’s Hospital survey and Sidra Medicine is considered one the finest children’s hospitals in the Middle East, so we anticipate great synergy to benefit patient care and research in the years to come.” Sidra Medicine’s Heart Center offers comprehensive care for congenital and acquired heart conditions, supported by a world-class team and cutting-edge facilities. It delivers preventative, medical, and surgical treatments through a collaborative, one-stop care model.

Copy 01/05/2025 10.